Sana Biotechnology, Inc. (SANA)

USD 1.69

(-11.78%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 30.86 Million 27.73 Million 17.91 Million 10.17 Million 3.92 Million 1000.00
Gross Profit -30.86 Million -27.73 Million -17.91 Million -10.17 Million -3.92 Million -1000.00
Operating Expenses 294.94 Million 272.56 Million 356.9 Million 286.14 Million 141.15 Million 8.22 Million
Selling, General and Administrative Expenses 73.29 Million 71.56 Million 50.41 Million 28.27 Million 21.77 Million 4.2 Million
Research and Development Expenses 221.64 Million 201 Million 306.49 Million 257.87 Million 119.37 Million 4.01 Million
Other Expenses - -674 Thousand 305 Thousand 97 Thousand -29 Thousand -
Cost and Expenses 325.8 Million 272.56 Million 356.9 Million 286.14 Million 141.15 Million 8.22 Million
Operating Income -326.9 Million -272.56 Million -356.9 Million -286.14 Million -141.15 Million -8.22 Million
Interest Expense - - - - - -
Income Tax Expense - -3.08 Million -11.74 Million -6.66 Million -7.54 Million -
Earnings before Tax -283.25 Million -269.47 Million -355.92 Million -285.3 Million -138.32 Million -13.24 Million
Net Income -283.25 Million -266.38 Million -344.18 Million -278.63 Million -130.77 Million -13.24 Million
Earnings Per Share Basic -1.46 -1.41 -2.07 -1.49 -0.70 -0.07
Earnings Per Share Diluted -1.46 -1.41 -2.07 -1.49 -0.70 -0.07
Weighted Average Shares Outstanding 194.54 Million 188.34 Million 166.43 Million 187.5 Million 187.33 Million 187.33 Million
Weighted Average Shares Outstanding (Diluted) 194.54 Million 188.34 Million 166.43 Million 187.5 Million 187.33 Million 187.33 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -252.39 Million -256.93 Million -356.9 Million -287.03 Million -138.9 Million -13.24 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts